Price CRASH: Should you buy GBST Holdings Limited?

GBST Holdings Limited (ASX:GBT) has been punished after a profit downgrade but is this a buying opportunity?

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Profit downgrades are never pretty and when the markets are jittery and on edge, any bad news is punished severely.

This has been the case with software provider GBST Holdings Limited (ASX: GBT) after releasing a market update on Tuesday. The share price has now plunged more than 30% since the announcement and more than 47% from its 52-week high of $6.84.

GBST is a provider of platform software to the financial services industry in Australia, Europe, Asia and North America. GBST comprises two divisions including Capital Markets and Wealth Management. In that it sense it has similarities to more established provider Iress Ltd (ASX: IRE).

Worryingly for investors (including myself), the long-serving managing director announced his intention to retire less than a month ago and this has compounded the negativity surrounding the stock as some investors begin to link the two announcements together.

More concerning for investors, however, should be the fact that GBST announced this profit warning only two months after releasing strong Financial Year 2015 (FY15) results. Although market conditions can change quite quickly, GBST provided an upbeat outlook and there was no warning about the potential for delays and timing issues that the company may face in the year ahead.

Despite the recent plunge in the share price, GBST still remains one of the best performing technology stocks on the ASX over the last five years with an annualised return of 38% per year.

Investors will now be asking – "Is this a temporary hiccup or a sign that the best is over for GBST?"

To answer this, it is important to take a closer look at the reasons behind the profit downgrade and the revised outlook.

In terms of the profit downgrade, GBST now expects that EBITDA could potentially be 22% lower in FY16 compared to FY15 with the majority of earnings weighted to the second half. These figures do not include the costs to replace the current managing director and the recruitment costs for the replacement.

The cause of the reduced profit comes down primarily to two factors. Firstly, GBST has experienced delays in rolling out some of its products to major clients and this will affect the annuity streams that come from these products. Secondly, GBST has already committed to additional spending and staffing costs to manage the anticipated growth over the coming year.

The company's revised outlook remains upbeat and it expects to return to growth in FY17. For many investors, FY17 is just too far away and I think many of them would prefer to wait until FY17 before putting their hard earned money into the business.

Personally, I think the issues facing GBST are short term in nature and have actually resulted from a company that has experienced rapid growth and not been able to meet the growing demand for its products. The company remains in a healthy financial position with minimal debt and strong positive cash flows.

At the current $3.60 share price, I think investors who are willing to hold the stock and remain patient may be pleasantly rewarded. With that said, it is unlikely the share price will make a significant recovery in the short term as the market waits until GBST finds a new CEO and at the very least, meets its new revised guidance.

While GBST might be a little high risk for some investors, the experts at The Motley Fool have found three dividend stocks that smash current term deposit rates and still offer the potential for excellent capital gains…

Motley Fool contributor Christopher Georges owns shares in GBST Holdings. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »